Search
Lexeo Therapeutics Inc
LXEOAdd to Watchlist
4.480USD
-0.180-3.86%
Close 07-27 16:00（ET）Quotes delayed by 15 min
331.89MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-27The current earnings forecast score of Lexeo Therapeutics Inc is 9.09, ranking 11 out of 386 in the Biotechnology & Medical Research industry. The average price target is 18.50, with a high of 30.00 and a low of 12.00.
Analyst Rating
Based on
10
analysts
Strong Buy
Current Rating
21.889
Target Price
+369.72%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Lexeo Therapeutics Inc
LXEO
10
Beigene Ltd
ONC
28
argenx SE
ARGX
26
Ionis Pharmaceuticals Inc
IONS
26
IQVIA Holdings Inc
IQV
25
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Lexeo Therapeutics Inc's price target?
Analysts forecast that Lexeo Therapeutics Inc's price target is USD 18.50, with the highest forecast at USD 30.00 and the lowest forecast at USD 12.00.
How have Lexeo Therapeutics IncLXEO's recent earnings per share performed?
The market expectation was USD -0.25, while Lexeo Therapeutics IncLXEO's earnings per share (EPS) for the previous quarter was USD -0.27. EPS for the next quarter is expected at USD -0.28.
What is the analyst rating for Lexeo Therapeutics Inc?
Based on the ratings of Lexeo Therapeutics Inc's stock from 10 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.